Few Blockbusters So Far From China’s First-In-Class Innovation

Mixed Fortunes For Pioneers

 
• By Dexter Jie Yan
  
Pair of hands on the red ground of a race track, with a white number one painted on it
Since 2019, a total of ten Chinese homegrown first-in-class drugs have hit the road of commercialization.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Scrip